GLOBAL PACKAGING AUTOMATION LIMITED

1. Financial Health Score: C+

Explanation: The patient is not in intensive care, but is suffering from a chronic, progressive wasting condition. While the company possesses a strong immune system against short-term creditors (excellent liquidity) and carries no dangerous "toxins" (long-term debt), it has been steadily losing financial mass. Shareholders' funds have eroded by over 60% since the 2021 peak. This score reflects a business that is currently solvent but shrinking, either through sustained trading losses or aggressive extraction of value, with little sign of recent reinvestment.

2. Key Vital Signs

• Blood Pressure (Liquidity): 110/70 – Healthy. The current ratio stands at approximately 3.6 (Current Assets £107,524 vs Current Liabilities £29,946). The company has more than enough liquid resources to meet its immediate obligations. There is no risk of a sudden "cardiac arrest" from creditor demands.
• Body Mass (Total Assets): Shrinking. Total assets have reduced from a peak of £418,574 in 2020 to £135,559 in 2024. The business is significantly smaller than it was five years ago.
• Cholesterol (Liabilities): Low. Total liabilities are £29,946. The company operates with very low leverage, meaning it is not clogging its arteries with debt.
• Muscle Tone (Fixed Assets): Atrophying. Fixed assets dropped from £37,379 in 2023 to £28,035 in 2024. This suggests the business is consuming its equipment (depreciation) without replacing it (capital expenditure), indicating a lack of investment in future capacity.
• Red Blood Cells (Shareholders' Funds/Equity): Dropping. Net assets fell from £158,680 to £105,613 in the last year alone—a drop of nearly £53,000. This represents a significant hemorrhage of value from the business.

3. Diagnosis

Diagnosis: Chronic Atrophy with Suspected Value Extraction

The financial data reveals a business that is "harvesting" rather than growing. The patient is stable but shrinking.

The most concerning symptom is the consistent and severe drop in Shareholders' Funds over the last four years (from £270,586 in 2021 to £105,613 in 2024). Because the company files as a micro-entity, we cannot see the Profit & Loss account directly, but this equity drop has only two possible causes:

1. Trading Hemorrhage: The business is making significant losses year after year.
2. Value Extraction: The business is profitable, but the directors (Mr. and Mrs. Hobson) are extracting funds via dividends faster than the company is generating profit.

Given the reduction in Fixed Assets and the lack of new investment, the prognosis leans towards a combination of both. The company appears to be in a "run-off" phase, where it is fulfilling existing orders with existing machinery but not investing in new equipment to secure future revenue. The "muscle" is being consumed to feed the "body" (the directors' remuneration), rather than being built up through reinvestment.

4. Recommendations

1. Stop the Bleeding (Identify the Source): The directors must determine if the equity drop is due to trading losses or dividend policy. If the business is trading at a loss, immediate steps must be taken to cut costs or increase margins. If it is profitable but paying out excessive dividends, the payout ratio must be reduced to preserve capital.
2. Physical Therapy (Reinvest in Assets): The reduction in fixed assets suggests the machinery is aging. As a manufacturer of packaging machinery (SIC 28930), the company's ability to generate revenue depends on its equipment. A plan for capital reinvestment is critical to prevent the business from becoming technically insolvent or unable to trade.
3. Nutritional Support (Cash Flow Management): While cash is currently adequate, the sharp drop in Current Assets (from £155k to £107k) suggests the liquidity buffer is thinning. Careful management of working capital is needed to ensure the business doesn't become "anemic" if a large unexpected expense arises.
4. Long-term Health Plan: With only 2 employees, this is a lifestyle business. The directors should clarify their long-term strategy: are they looking to sell the asset (the business), wind it down, or revive it? The current trajectory suggests a wind-down.